| Parameter | Any PP N = 322 |
| PP < 70 mmHg N = 207 | PP ≥ 70 mmHg N = 115 | Between group p-value |
| Females: n (%) | 141 (43.8) |
| 88 (42.5) | 53 (46.1) | 0.536 |
| Age, years: mean ± SD | 66.5 ± 15.6 |
| 62.8 ± 15 | 73.7 ± 13.4 | <0.001 |
| Age < 50 years old: n (%) | 42 (13) |
| 37 (17.9) | 5 (4.3) | <0.001 |
| Age 50 - 69 years old: n (%) | 134 (41.6) |
| 97 (46.9) | 37 (32.2) | |
| Age 70 years or older: n (%) | 146 (45.3) |
| 73 (35.3) | 73 (63.5) | |
| History of CAD: n (%) | 81 (25.2) |
| 46 (22.2) | 35 (30.4) | 0.104 |
| No CAD history | 241 (74.8) |
| 161 (77.8) | 80 (69.6) | 0.110 |
| CAD w/o revascularization | 41 (12.7) |
| 27 (13) | 14 (12.2) | |
| CAD with CABG history | 21 (6.5) |
| 9 (4.3) | 12 (10.4) | |
| CAD with PCI history | 19 (5.9) |
| 10 (4.8) | 9 (7.8) | |
| History of hypertension: n (%) | 237 (73.6) |
| 141 (68.1) | 96 (83.5) | 0.003 |
| History of diabetes: n (%) | 94 (29.2) |
| 60 (29) | 34 (29.6) | 0.913 |
| History of dyslipidemia: n (%) | 183 (56.8) |
| 113 (54.6) | 70 (60.9) | 0.276 |
| History of peripheral vascular disease: n (%) | 190 (59) |
| 113 (54.6) | 77 (67) | 0.031 |
| Creatinine > 2 mg/dL or HD: n (%) | 15 (4.7) |
| 8 (3.9) | 7 (6.1) | 0.365 |
| First recorded SBP, mmHg: mean ± SD | 148.6 ± 29.7 |
| 133.7 ± 20.6 | 175.5 ± 24 | <0.001 |
| First recorded DBP, mmHg: mean ± SD | 84.6 ± 17.2 |
| 83.9 ± 16.2 | 85.9 ± 18.8 | 0.331 |
| First recorded pulse pressure, mmHg: mean ± SD | 64 ± 23 |
| 49.85 ± 12 | 89.65 ± 14 | <0.001 |
| Pulse pressure ≥ 70 mmHg: n (%) | 115 (35.7) |
|
| ||
| Type of stroke: n (%) |
|
|
|
|
|
| Embolic | 191 (59.3) |
| 120 (58) | 71 (61.7) | 0.051 |
| Lacunar | 39 (12.1) |
| 20 (9.7) | 19 (16.5) | |
| Transient ischemic attack | 92 (28.6) |
| 67 (32.4) | 25 (21.7) | |
| Admission Glasgow coma scale, units: mean ± SD | 13.6 ± 1.9 |
| 13.7 ± 1.7 | 13.4 ± 2 | 0.173 |
| Beta-Blockers: n (%) | 174 (54) |
| 100 (48.3) | 74 (64.3) | 0.005 |
| ACEI or ARB: n (%) | 206 (64) |
| 116 (56) | 90 (78.3) | <0.001 |
| ACEI or ARB with beta-blocker | 128 (39.8) |
| 66 (31.9) | 62 (53.9) | <0.001 |
| Beta-blocker without ACEI or ARB | 46 (14.3) |
| 34 (16.4) | 12 (10.4) | |
| ACEI or ARB without beta-blocker | 78 (24.2) |
| 50 (24.2) | 28 (24.3) | |
| No ACEI or ARB, no beta-blocker | 70 (21.7) |
| 57 (27.5) | 13 (11.3) | |
| Diuretics: n (%) | 33 (10.2) |
| 20 (9.7) | 13 (11.3) | 0.642 |
| Other anti-HTN Rx: n (%) | 9 (2.8) |
| 3 (1.5) | 6 (5.2) | 0.145 |
| Interval to target blood pressure, days: mean ± SD | 5.5 ± 8.4 |
| 1.7 ± 1.2 | 7.8 ± 10.2 | 0.355 |
| In-hospital mortality: n (%) | 17/322 (5.3) |
| 9 (4.3) | 8 (7) | 0.316 |
| Follow-up length, months: mean ± SD | 49.7 ± 22.4 |
| 51.4 ± 21.9 | 47 ± 22.7 | 0.092 |
| Follow-up mortality: n (%) | 86/305 (28.2) |
| 46/198 (23.2) | 40/107 (37.4) | 0.009 |